Interwest Venture Management

Latest statistics and disclosures from Interwest Venture Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Pmv Pharmaceuticals, REAL, GKOS, AGTC, EIGR, and represent 95.44% of Interwest Venture Management's stock portfolio.
  • Added to shares of these 1 stocks: Pmv Pharmaceuticals (+$230M).
  • Started 1 new stock positions in Pmv Pharmaceuticals.
  • Reduced shares in these 1 stocks: REAL (-$19M).
  • Interwest Venture Management was a net buyer of stock by $211M.
  • Interwest Venture Management has $347M in assets under management (AUM), dropping by 187.39%.

Tip: Access up to 7 years of quarterly data

Positions held by INTERWEST VENTURE MANAGEMENT consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Interwest Venture Management

Companies in the Interwest Venture Management portfolio as of the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Pmv Pharmaceuticals 66.3 $230M NEW 6.5M 35.50
Realreal (REAL) 16.1 $56M -25% 3.9M 14.47
Glaukos (GKOS) 9.2 $32M 646k 49.52
Applied Genetic Technol Corp C (AGTC) 2.0 $7.1M 1.5M 4.86
Eiger Biopharmaceuticals (EIGR) 1.8 $6.2M 765k 8.14
Neuronetics (STIM) 1.4 $5.0M 1.0M 4.86
Kalvista Pharmaceuticals (KALV) 1.4 $4.9M 389k 12.59
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) 1.1 $3.9M 1.4M 2.85
Venus Concept (VERO) 0.4 $1.5M 659k 2.32
Obalon Therapeutics (OBLN) 0.1 $346k 380k 0.91
Xenon Pharmaceuticals (XENE) 0.0 $92k 8.3k 11.09
Dare Bioscience (DARE) 0.0 $50k 50k 0.99

Past Filings by Interwest Venture Management

SEC 13F filings are viewable for Interwest Venture Management going back to 2016